Stay updated with breaking news from கிரேவ் ல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
17 February 2021 | 08:11am StockMarketWire.com - Medical device company Creo Medical said annual performance was marginally ahead of management s expectation amid ongoing commerical progress thanks to a boost from acquisitions. For the year ended 31 December 2020, revenue jumped to over £9 million from £0.01 million a year earlier, with net cash position in excess of £45 million. The acquisitions of Albyn Medical S.L. and Boucart Medical SRL provided the company with a direct sales presence in Europe to facilitate the roll-out of its CE marked advanced energy devices, and strengthen Creo s EU and UK commercial teams, the company said. In 2021, the immediate focus for the company is to deliver clinical outcomes for all devices, Creo said. ....